Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
19/08/2026 14:54
BRIEF-Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan Aug 19 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS:
SUBSIDIARY INCORPORATED DR LAL PATHLABS INDOMED IN TASHKENT, UZBEKISTAN
Source text: ID:nBSE7GkR8l
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise